These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 23674815)

  • 1. Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.
    Clem BF; O'Neal J; Tapolsky G; Clem AL; Imbert-Fernandez Y; Kerr DA; Klarer AC; Redman R; Miller DM; Trent JO; Telang S; Chesney J
    Mol Cancer Ther; 2013 Aug; 12(8):1461-70. PubMed ID: 23674815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
    Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
    Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
    Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
    J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
    Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
    J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3.
    Liu X; Zhao Y; Zhang E; Yan H; Lv N; Cai Z
    Biochem Biophys Res Commun; 2019 Jul; 515(2):332-338. PubMed ID: 31153642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
    Imbert-Fernandez Y; Clem BF; O'Neal J; Kerr DA; Spaulding R; Lanceta L; Clem AL; Telang S; Chesney J
    J Biol Chem; 2014 Mar; 289(13):9440-8. PubMed ID: 24515104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells.
    Kotowski K; Supplitt S; Wiczew D; Przystupski D; Bartosik W; Saczko J; Rossowska J; Drąg-Zalesińska M; Michel O; Kulbacka J
    Anticancer Res; 2020 May; 40(5):2613-2625. PubMed ID: 32366406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor.
    Chesney J; Clark J; Lanceta L; Trent JO; Telang S
    Oncotarget; 2015 Jul; 6(20):18001-11. PubMed ID: 26221874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Growth by Combined Treatment with Inhibitors of Lactate Dehydrogenase and either Phenformin or Inhibitors of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase 3.
    Lea MA; Guzman Y; Desbordes C
    Anticancer Res; 2016 Apr; 36(4):1479-88. PubMed ID: 27069123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
    Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
    Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer.
    Zhu W; Ye L; Zhang J; Yu P; Wang H; Ye Z; Tian J
    PLoS One; 2016; 11(9):e0163768. PubMed ID: 27669567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.
    Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y
    J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
    Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
    FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PFKFB3 inhibitors as potential anticancer agents: Mechanisms of action, current developments, and structure-activity relationships.
    Wang Y; Qu C; Liu T; Wang C
    Eur J Med Chem; 2020 Oct; 203():112612. PubMed ID: 32679452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3).
    Brooke DG; van Dam EM; Watts CK; Khoury A; Dziadek MA; Brooks H; Graham LJ; Flanagan JU; Denny WA
    Bioorg Med Chem; 2014 Feb; 22(3):1029-39. PubMed ID: 24398380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PFKFB3 promotes endotoxemia-induced myocardial dysfunction through inflammatory signaling and apoptotic induction.
    Tian W; Guo HS; Li CY; Cao W; Wang XY; Mo D; Hao XW; Feng YD; Sun Y; Lei F; Zhang HN; Zhao MG; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 368():26-36. PubMed ID: 30776389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
    Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP
    J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis.
    Zou Y; Zeng S; Huang M; Qiu Q; Xiao Y; Shi M; Zhan Z; Liang L; Yang X; Xu H
    Br J Pharmacol; 2017 May; 174(9):893-908. PubMed ID: 28239846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism.
    Klarer AC; O'Neal J; Imbert-Fernandez Y; Clem A; Ellis SR; Clark J; Clem B; Chesney J; Telang S
    Cancer Metab; 2014 Jan; 2(1):2. PubMed ID: 24451478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.